Geriatric
Ibrutinib and venetoclax demonstrated superior MRD responses in older/unfit patients with previously untreated CLL.
Older patients are at a significantly increased risk of immune-related AEs.
Researchers evaluated the effectiveness of a personalized sequential therapy for older patients with multiple myeloma.
The use of hematopoietic stem cell transplantation (AHCT) is associated with excellent 2-year outcomes in multiple myeloma ...
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.